Marker Therapeutics Stock Probability of Future Stock Price Finishing Over 4.31
| MRKR Stock | USD 4.22 0.02 0.48% |
Marker |
Marker Therapeutics Target Price Odds to finish over 4.31
The tendency of Marker Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 4.31 or more in 90 days |
| 4.22 | 90 days | 4.31 | about 47.43 |
Based on a normal probability distribution, the odds of Marker Therapeutics to move over $ 4.31 or more in 90 days from now is about 47.43 (This Marker Therapeutics probability density function shows the probability of Marker Stock to fall within a particular range of prices over 90 days) . Probability of Marker Therapeutics price to stay between its current price of $ 4.22 and $ 4.31 at the end of the 90-day period is about 11.5 .
Given the investment horizon of 90 days Marker Therapeutics has a beta of -0.0723. This indicates as returns on the benchmark increase, returns on holding Marker Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Marker Therapeutics is likely to outperform the market. Additionally Marker Therapeutics has an alpha of 0.002, implying that it can generate a 0.002045 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Marker Therapeutics Price Density |
| Price |
Predictive Modules for Marker Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Marker Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Marker Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Marker Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Marker Therapeutics is not an exception. The market had few large corrections towards the Marker Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Marker Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Marker Therapeutics within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0 | |
β | Beta against NYSE Composite | -0.07 | |
σ | Overall volatility | 0.31 | |
Ir | Information ratio | -0.01 |
Marker Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Marker Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Marker Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Marker Therapeutics generated a negative expected return over the last 90 days | |
| Marker Therapeutics has high historical volatility and very poor performance | |
| Marker Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.31 M. Net Loss for the year was (14.05 M) with loss before overhead, payroll, taxes, and interest of (17.13 M). | |
| Marker Therapeutics currently holds about 18.08 M in cash with (16.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22. | |
| Marker Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 12.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Hoang Tsvetelina P of 33159 shares of Marker Therapeutics at 2.14 subject to Rule 16b-3 |
Marker Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Marker Stock often depends not only on the future outlook of the current and potential Marker Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Marker Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.8 M | |
| Cash And Short Term Investments | 15.1 M |
Marker Therapeutics Technical Analysis
Marker Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Marker Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Marker Therapeutics. In general, you should focus on analyzing Marker Stock price patterns and their correlations with different microeconomic environments and drivers.
Marker Therapeutics Predictive Forecast Models
Marker Therapeutics' time-series forecasting models is one of many Marker Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Marker Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Marker Therapeutics
Checking the ongoing alerts about Marker Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Marker Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Marker Therapeutics generated a negative expected return over the last 90 days | |
| Marker Therapeutics has high historical volatility and very poor performance | |
| Marker Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.31 M. Net Loss for the year was (14.05 M) with loss before overhead, payroll, taxes, and interest of (17.13 M). | |
| Marker Therapeutics currently holds about 18.08 M in cash with (16.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22. | |
| Marker Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 12.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Hoang Tsvetelina P of 33159 shares of Marker Therapeutics at 2.14 subject to Rule 16b-3 |
Check out Marker Therapeutics Backtesting, Marker Therapeutics Valuation, Marker Therapeutics Correlation, Marker Therapeutics Hype Analysis, Marker Therapeutics Volatility, Marker Therapeutics History as well as Marker Therapeutics Performance. To learn how to invest in Marker Stock, please use our How to Invest in Marker Therapeutics guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Marker Stock analysis
When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Marker Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Marker Therapeutics. If investors know Marker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Marker Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.59) | Revenue Per Share 0.376 | Quarterly Revenue Growth 0.392 | Return On Assets (0.35) | Return On Equity (0.83) |
The market value of Marker Therapeutics is measured differently than its book value, which is the value of Marker that is recorded on the company's balance sheet. Investors also form their own opinion of Marker Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Marker Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Marker Therapeutics' market value can be influenced by many factors that don't directly affect Marker Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Marker Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Marker Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marker Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.